Ann: IHL-675A outperforms existing treatment for arthritis, page-125

I don’t disagree with anything you have written about the company. I would like to understand about your comment on Peter Widdows and get your perspective of his role and potential contribution for IHL’s success. Why you think he is invaluable?

I could only glean from his bio and IHL’s Ann from his appointment in March 2018 that he was head of Heinz Australia and grew its revenues and profits. He has strong FMCG supply chain and business knowledge. How is this relevant to IHL where it is today as a biotech in the CBD/ Psilocybin drugs? Can you please share some thoughts?

Thanks.